FDA drug center head Tracy Beth Høeg leaves as agency faces leadership vacuum

AI justification

Leadership vacuum at FDA undermines public health protections and drug safety oversight. | The resignations create a leadership vacuum at a critical health regulatory agency, directly undermining public health protections and the right to medical care. While personnel changes may eventually lead to reform, the immediate impact is a destabilization of drug safety oversight with potential long-term consequences for patient welfare.